National Vision Holdings Inc (EYE)

Days of sales outstanding (DSO)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Receivables turnover
DSO days

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —

Based on the data provided, National Vision Holdings Inc has not disclosed the specific number of days of sales outstanding (DSO) for any of the reporting periods from March 31, 2020, to December 31, 2024. The absence of DSO figures limits our ability to analyze the efficiency of the company's accounts receivable management and the time it takes to collect on sales.

DSO is a crucial financial ratio that provides insights into the average number of days it takes for a company to collect payments from its customers. A lower DSO typically indicates more efficient accounts receivable management and faster cash conversion cycle, while a higher DSO may suggest potential issues with credit policies or collections that could impact cash flow and liquidity.

Without the specific DSO figures for National Vision Holdings Inc, it is challenging to assess the company's effectiveness in managing its accounts receivable and monitoring its cash flow. Investors and stakeholders often rely on DSO as an important metric to evaluate a company's financial health and operational efficiency. We recommend monitoring future financial reports for the disclosure of DSO figures to gain a better understanding of National Vision Holdings Inc's performance in this key area.


Peer comparison

Dec 31, 2024

Company name
Symbol
DSO
National Vision Holdings Inc
EYE
STAAR Surgical Company
STAA
The Cooper Companies, Inc. Common Stock
COO
67.70